Activation of YAP/TAZ by loss of the Hippo pathway kinases Lats1 and Lats2 in tumor cells of different murine syngeneic tumor models of melanoma, head and neck carcinoma, and breast cancer enhanced anti-tumor immune responses that lead to cancer cell elimination57. The gene discussed is LATS1; the disease is melanoma.